PCNA and Hermansky-Pudlak syndrome: Moreover, the hepatocyte proliferation was markedly higher in HPS-treated animals compared to control mice at 96 h after D-GalN challenge, as measured by proliferating cell nuclear antigen (PCNA) staining (Figure 4G).